Roche’s tocilizumab cuts deaths in hospitalized COVID-19 patients, study suggests

Roche’s arthritis drug tocilizumab cuts the risk of death among patients hospitalized with severe COVID-19, also shortening the time to recovery and reducing the need for mechanical ventilation, a large clinical trial suggests.